2025-2031 Global Modified Antibody Industry Research & Trends Analysis Report

2025-2031 Global Modified Antibody Industry Research & Trends Analysis Report

  • Publication Date: 2025-09-18
  • Report Id: 2405156
  • Industry: Medical Care
  • Report Page: 138
  • Chart: 133
sample
customized
pdf

PDF Download

  • Publication Date: 2025-09-18
  • Report Id: 2405156
  • Industry: Medical Care
  • Report Page: 138
  • Chart: 133
sample
customized
pdf

PDF Download

  • Table of Contents
  • Description
  • Table of Figures
  • Need a Quote? quote

1 Market Overview
1.1 Modified Antibody Definition
1.2 Global Modified Antibody Market Size and Forecast
1.2.1 By Revenue, Global Modified Antibody Market Size, 2020-2031
1.2.2 By Sales Volume, Global Modified Antibody Market Size, 2020-2031
1.2.3 Global Modified Antibody Price Trend, 2020-2031
1.3 China Modified Antibody Market Size and Forecast
1.3.1 By Revenue, China Modified Antibody Market Size, 2020-2031
1.3.2 By Sales Volume, China Modified Antibody Market Size, 2020-2031
1.3.3 China Modified Antibody Price Trend, 2020-2031
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Modified Antibody Share in Global Market, 2020-2031
1.4.2 By Sales Volume, China Modified Antibody Share in Global Market, 2020-2031
1.4.3 Modified Antibody Market Size: China VS Global, 2020-2031
1.5 Modified Antibody Market Dynamics
1.5.1 Modified Antibody Market Drivers
1.5.2 Modified Antibody Market Restraints
1.5.3 Modified Antibody Industry Trends
1.5.4 Modified Antibody Industry Policy

2 Global Competitive Landscape by Company
2.1 Global Modified Antibody Revenue by Company, 2020-2025
2.2 Global Modified Antibody Sales Volume by Company, 2020-2025
2.3 Global Modified Antibody Price by Company, 2020-2025
2.4 Global Modified Antibody Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Modified Antibody Concentration Ratio
2.6 Global Modified Antibody Mergers & Acquisitions, Expansion Plans
2.7 Global Modified Antibody Manufacturers Product Type

3 China Competitive Landscape by Company
3.1 China Modified Antibody Revenue by Company, 2020-2025
3.2 China Modified Antibody Sales Volume by Company, 2020-2025
3.3 China Modified Antibody Modified Antibody Participants, Market Position (Tier 1, Tier 2, and Tier 3)
3.4 China Modified Antibody Market, Sales Percentage of Local Players VS Foreign Players (2020-2025)
3.5 Chinese Local Players, Modified Antibody Domestic VS Export
3.6 China Market, Modified Antibody Import & Export
3.6.1 China Market, Modified Antibody Import & Export, 2020-2031
3.6.2 China Modified Antibody Import & Export Trends
3.6.3 Main Sources of China Modified Antibody Import
3.6.4 Export Destination of China Modified Antibody

4 Modified Antibody Production by Region
4.1 Global Modified Antibody Capacity, Production and Capacity Utilization, 2020-2031
4.2 Global Geographic Distribution of Modified Antibody Manufacturers
4.3 Global Major Manufacturers, Modified Antibody Capacity Expansion and Future Plans
4.4 Global Modified Antibody Capacity by Region
4.5 Global Modified Antibody Production by Region
4.5.1 Global Modified Antibody Production & Forecast by Region, 2020 VS 2024 VS 2031
4.5.2 Global Modified Antibody Production by Region, 2020-2025
4.5.3 Global Modified Antibody Production Market Share & Forecast by Region, 2020-2031

5 Industry Chain Analysis
5.1 Modified Antibody Industry Chain
5.2 Modified Antibody Upstream Analysis
5.2.1 Modified Antibody Core Raw Materials
5.2.2 Main Manufacturers of Modified Antibody Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Modified Antibody Production Mode
5.6 Modified Antibody Procurement Model
5.7 Modified Antibody Industry Sales Model and Sales Channels
5.7.1 Modified Antibody Sales Model
5.7.2 Modified Antibody Typical Distributors

6 Sights by Type
6.1 Modified Antibody Classification by Type
6.1.1 Histone Modification Antibodies
6.1.2 Non-Histone Modification Antibodies
6.2 by Type, Global Modified Antibody Market Size & CAGR, 2020 VS 2024 VS 2031
6.3 by Type, Global Modified Antibody Revenue, 2020-2031
6.4 by Type, Global Modified Antibody Sales Volume, 2020-2031
6.5 by Type, Global Modified Antibody Price, 2020-2031

7 Sights by Application
7.1 Modified Antibody Segment by Application
7.1.1 Cancer Treatment
7.1.2 Immunopathy Treatment
7.1.3 Diagnosis
7.1.4 Scientific Research
7.1.5 Others
7.2 by Application, Global Modified Antibody Market Size & CAGR, 2020 VS 2024 VS 2031
7.3 by Application, Global Modified Antibody Revenue, 2020-2031
7.4 by Application, Global Modified Antibody Sales Volume, 2020-2031
7.5 by Application, Global Modified Antibody Price, 2020-2031

8 Sales Sights by Region
8.1 By Region, Global Modified Antibody Market Size, 2020 VS 2024 VS 2031
8.2 By Region, Global Modified Antibody Revenue, 2020-2031
8.3 By Region, Global Modified Antibody Sales Volume, 2020-2031
8.4 North America
8.4.1 North America Modified Antibody Market Size & Forecasts, 2020-2031
8.4.2 By Country, North America Modified Antibody Market Size Market Share
8.5 Europe
8.5.1 Europe Modified Antibody Market Size & Forecasts, 2020-2031
8.5.2 By Country, Europe Modified Antibody Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Modified Antibody Market Size & Forecasts, 2020-2031
8.6.2 By Country/Region, Asia Pacific Modified Antibody Market Size Market Share
8.7 South America
8.7.1 South AmericaModified Antibody Market Size & Forecasts, 2020-2031
8.7.2 By Country, South America Modified Antibody Market Size Market Share
8.8 Middle East & Africa

9 Sales Sights by Country Level
9.1 By Country, Global Modified Antibody Market Size & CAGR,2020 VS 2024 VS 2031
9.2 By Country, Global Modified Antibody Revenue, 2020-2031
9.3 By Country, Global Modified Antibody Sales Volume, 2020-2031
9.4 United States
9.4.1 United States Modified Antibody Market Size, 2020-2031
9.4.2 By Company, United States Modified Antibody Sales Volume Market Share, 2024
9.4.3 by Type, United States Modified Antibody Market Size, Share, 2024 VS 2031
9.4.4 by Application, United States Modified Antibody Market Size, Share, 2024 VS 2031
9.5 Europe
9.5.1 Europe Modified Antibody Market Size, 2020-2031
9.5.2 By Company, Europe Modified Antibody Sales Volume Market Share, 2024
9.5.3 by Type, Europe Modified Antibody Market Size, Share, 2024 VS 2031
9.5.4 by Application, Europe Modified Antibody Market Size, Share, 2024 VS 2031
9.6 China
9.6.1 China Modified Antibody Market Size, 2020-2031
9.6.2 By Company, China Modified Antibody Sales Volume Market Share, 2024
9.6.3 by Type, China Modified Antibody Market Size, Share, 2024 VS 2031
9.6.4 by Application, China Modified Antibody Market Size, Share, 2024 VS 2031
9.7 Japan
9.7.1 Japan Modified Antibody Market Size, 2020-2031
9.7.2 By Company, Japan Modified Antibody Market Share, 2024
9.7.3 by Type, Japan Modified Antibody Market Size, Share, 2024 VS 2031
9.7.4 by Application, Japan Modified Antibody Market Size, Share, 2024 VS 2031
9.8 South Korea
9.8.1 South Korea Modified Antibody Market Size, 2020-2031
9.8.2 By Company, South Korea Modified Antibody Market Share, 2024
9.8.3 by Type, South Korea Modified Antibody Market Size, Share, 2024 VS 2031
9.8.4 by Application, South Korea Modified Antibody Market Size, Share, 2024 VS 2031
9.9 Southeast Asia
9.9.1 Southeast Asia Modified Antibody Market Size, 2020-2031
9.9.2 By Company, Southeast Asia Modified Antibody Market Share, 2024
9.9.3 by Type, Southeast Asia Modified Antibody Market Size, Share, 2024 VS 2031
9.9.4 by Application, Southeast Asia Modified Antibody Market Size, Share, 2024 VS 2031
9.10 India
9.10.1 India Modified Antibody Market Size, 2020-2031
9.10.2 By Company, India Modified Antibody Market Share, 2024
9.10.3 by Type, India Modified Antibody Market Size, Share, 2024 VS 2031
9.10.4 by Application, India Modified Antibody Market Size, Share, 2024 VS 2031
9.11 Middle East & Africa
9.11.1 Middle East & Africa Modified Antibody Market Size, 2020-2031
9.11.2 By Company, Middle East & Africa Modified Antibody Market Share, 2024
9.11.3 by Type, Middle East & Africa Modified Antibody Market Size, Share, 2024 VS 2031
9.11.4 by Application, Middle East & Africa Modified Antibody Market Size, Share, 2024 VS 2031

10 Manufacturers Profile
10.1 RevMAb Biosciences
10.1.1 RevMAb Biosciences Company Information, Head Office, Market Area, and Industry Position
10.1.2 RevMAb Biosciences Modified Antibody Models, Specifications, and Application
10.1.3 RevMAb Biosciences Modified Antibody Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.1.4 RevMAb Biosciences Company Profile and Main Business
10.1.5 RevMAb Biosciences Recent Developments
10.2 Thermo Fisher Scientific
10.2.1 Thermo Fisher Scientific Company Information, Head Office, Market Area, and Industry Position
10.2.2 Thermo Fisher Scientific Modified Antibody Models, Specifications, and Application
10.2.3 Thermo Fisher Scientific Modified Antibody Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.2.4 Thermo Fisher Scientific Company Profile and Main Business
10.2.5 Thermo Fisher Scientific Recent Developments
10.3 BioCat GmbH
10.3.1 BioCat GmbH Company Information, Head Office, Market Area, and Industry Position
10.3.2 BioCat GmbH Modified Antibody Models, Specifications, and Application
10.3.3 BioCat GmbH Modified Antibody Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.3.4 BioCat GmbH Company Profile and Main Business
10.3.5 BioCat GmbH Recent Developments
10.4 Merck
10.4.1 Merck Company Information, Head Office, Market Area, and Industry Position
10.4.2 Merck Modified Antibody Models, Specifications, and Application
10.4.3 Merck Modified Antibody Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.4.4 Merck Company Profile and Main Business
10.4.5 Merck Recent Developments
10.5 ProteoGenix
10.5.1 ProteoGenix Company Information, Head Office, Market Area, and Industry Position
10.5.2 ProteoGenix Modified Antibody Models, Specifications, and Application
10.5.3 ProteoGenix Modified Antibody Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.5.4 ProteoGenix Company Profile and Main Business
10.5.5 ProteoGenix Recent Developments
10.6 Biorbyt
10.6.1 Biorbyt Company Information, Head Office, Market Area, and Industry Position
10.6.2 Biorbyt Modified Antibody Models, Specifications, and Application
10.6.3 Biorbyt Modified Antibody Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.6.4 Biorbyt Company Profile and Main Business
10.6.5 Biorbyt Recent Developments
10.7 Cusabio
10.7.1 Cusabio Company Information, Head Office, Market Area, and Industry Position
10.7.2 Cusabio Modified Antibody Models, Specifications, and Application
10.7.3 Cusabio Modified Antibody Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.7.4 Cusabio Company Profile and Main Business
10.7.5 Cusabio Recent Developments
10.8 Rockland
10.8.1 Rockland Company Information, Head Office, Market Area, and Industry Position
10.8.2 Rockland Modified Antibody Models, Specifications, and Application
10.8.3 Rockland Modified Antibody Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.8.4 Rockland Company Profile and Main Business
10.8.5 Rockland Recent Developments
10.9 Proteintech
10.9.1 Proteintech Company Information, Head Office, Market Area, and Industry Position
10.9.2 Proteintech Modified Antibody Models, Specifications, and Application
10.9.3 Proteintech Modified Antibody Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.9.4 Proteintech Company Profile and Main Business
10.9.5 Proteintech Recent Developments
10.10 PTM BIO
10.10.1 PTM BIO Company Information, Head Office, Market Area, and Industry Position
10.10.2 PTM BIO Modified Antibody Models, Specifications, and Application
10.10.3 PTM BIO Modified Antibody Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.10.4 PTM BIO Company Profile and Main Business
10.10.5 PTM BIO Recent Developments
10.11 Elabscience Biotechnology
10.11.1 Elabscience Biotechnology Company Information, Head Office, Market Area, and Industry Position
10.11.2 Elabscience Biotechnology Modified Antibody Models, Specifications, and Application
10.11.3 Elabscience Biotechnology Modified Antibody Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.11.4 Elabscience Biotechnology Company Profile and Main Business
10.11.5 Elabscience Biotechnology Recent Developments
10.12 AtaGenix
10.12.1 AtaGenix Company Information, Head Office, Market Area, and Industry Position
10.12.2 AtaGenix Modified Antibody Models, Specifications, and Application
10.12.3 AtaGenix Modified Antibody Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.12.4 AtaGenix Company Profile and Main Business
10.12.5 AtaGenix Recent Developments

11 Conclusion

12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer